Skip to main content
Minimal residual disease quantification using consensus primers and high-throughput IGH sequencing predicts post-transplant relapse in chronic lymphocytic leukemia.
Published Web Location
http://europepmc.org/articles/PMC3740398?pdf=renderNo data is associated with this publication.
Abstract
Quantification of minimal residual disease (MRD) following allogeneic hematopoietic cell transplantation (allo-HCT) predicts post-transplant relapse in patients with chronic lymphocytic leukemia (CLL). We utilized an MRD-quantification method that amplifie
Many UC-authored scholarly publications are freely available on this site because of the UC's open access policies. Let us know how this access is important for you.